Scholar Rock received FDA approval for ISEMBYLD, the first muscle-targeted therapy for spinal muscular atrophy (SMA), aimed at patients aged two and older already on other treatments. The drug is priced at $11,659 per vial and has earned a Rare Pediatric Disease Priority Review Voucher. Following this milestone, Jefferies raised Scholar Rock's price target from $57 to $65, reflecting optimism about the company's growth potential. The stock traded at $51.85 with a market cap of about $6.21 billion at the time of the update.
Scholar Rock's recent FDA approval news is presented here with Pluang's health sector market data as of Sep 15, 2026 19:14 WIB: Among 91 priced US health stocks, 28 rose and 59 fell. Notable movers include AMWL at USD 13.66 with a -1.51% change, HRTX at USD 0.32 with a +1.49% change, and CNC at USD 68.40 with a -1.41% change.
AIsa, an AI infrastructure startup, announced it has raised over $9 million in cumulative funding after Tether and HIVEN joined a seed extension round. The company connects AI agents to external data and services while managing usage, billing, and sp...
Worldcoin (WLD) experienced a price decline to $0.4797 on October 17, falling over 5% in the last hour and nearly 6% in 24 hours. The drop coincided with $800,000 in long position liquidations across Binance, Bybit, and OKX, while no short positions ...
Bitcoin wallets store private keys, not coins, which are entries on the blockchain. Setting up a wallet involves generating and securely storing a recovery phrase that can restore access to funds. Users must avoid shortcuts like skipping phrase verif...
Solana (SOL) experienced a 2.13% price decline within one hour, falling to $102 on Binance's spot market. Over the past 24 hours, SOL dropped 2.32%, with significant long positions totaling $8.6 million and minimal short positions of $60,000 recorded...
Bitcoin experienced $10.91 million in liquidations during the hour ending at 5:35 p.m. ET on October 17, with its price dropping 0.70% from $81,658 to $81,087. The liquidations included $10.44 million in long positions and $480,000 in short positions...
